Drugs Health Pharma

Kezar Life Sciences halts mid-stage lupus nephritis trial after four people die

Kezar Life Sciences Inc., a US-based biotechnology company, has stopped a trial in patients with a type of kidney disease after four people.

Read More
Drugs Health Pharma

Novartis’s drug to treat rare kidney disease gets USFDA approval 

Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of.

Read More
Drugs Health Pharma

New cardiovascular risk calculator may impose a burden on 16 million US citizens

HQ Team August 6, 2024: A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the.

Read More
Drugs Health Medical

Patients with burnt-out diabetes found to have underdiagnosed hyperglycemia: Study

HQ Team December 18, 2023: Investigative results from a pilot study showed that those with burnt-out diabetes and end-stage kidney disease experienced a.

Read More
Drugs Health Pharma

Novo Nordisk stops testing of Ozempic as kidney trial meets efficacy goals

HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people.

Read More
Drugs Health Medical

Bacteriophages effective in fast testing and treatment of UTIs

HQ Team July 22, 2023: Urinary tract infections (UTIs) affect nearly one in two women at least once in their lifetime. The growing.

Read More
Drugs Health Pharma

Novartis to acquire Chinook Therapeutics in a $3.5 billion deal

HQ Team June 13, 2023: Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental.

Read More
Drugs Health Medical

Oral semaglutide reduces HbA1c, weight in Type 2 diabetics, study reveals

HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the.

Read More
Drugs Health Medical

Kisspeptin hormone may cure hypoactive sexual desire disorder

Kisspeptin hormone could treat hypoactive sexual desire disorder when a person has an extremely low sex drive that causes distress, scientists from the.

Read More
Drugs Pharma

Combined dish-and-chip technology to open ways to treat kidney disorder

US scientists have combined two technologies to show the effect of glucose in polycystic kidney disorder, a life-threatening genetic disorder, according to a.

Read More
X